Sp679

UPDATE ON IAP GUIDELINES

Date
May 7, 2023
Explore related products in the following collection:

Society: SSAT


Tracks

Related Products

Thumbnail for LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES
LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES
LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM
Thumbnail for IMMUNOREACT 8: IMMUNE MARKERS AS PREDICTORS OF LOCAL TUMOR SPREAD IN PATIENTS UNDERGOING TRANSANAL EXCISION FOR RECTAL CANCER
IMMUNOREACT 8: IMMUNE MARKERS AS PREDICTORS OF LOCAL TUMOR SPREAD IN PATIENTS UNDERGOING TRANSANAL EXCISION FOR RECTAL CANCER
LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM
Thumbnail for LYMPH NODE YIELD IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL AND INCREASED TIME TO RECURRENCE IN NODE-NEGATIVE PANCREATIC DUCTAL ADENOCARCINOMA FOLLOWING NEOADJUVANT THERAPY
LYMPH NODE YIELD IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL AND INCREASED TIME TO RECURRENCE IN NODE-NEGATIVE PANCREATIC DUCTAL ADENOCARCINOMA FOLLOWING NEOADJUVANT THERAPY
Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…
Thumbnail for KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY
KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY
LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM